pyridoxamine phosphate has been researched along with Leukemia in 1 studies
pyridoxamine phosphate: RN given refers to parent cpd; structure
pyridoxamine 5'-phosphate : A vitamin B6 phosphate that is the phosphoric ester derivative of pyridoxamine.
Leukemia: A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chuvykin, MB | 1 |
| Pavlova, MP | 1 |
1 other study available for pyridoxamine phosphate and Leukemia
| Article | Year |
|---|---|
[Pyridoxal and pyridoxamine phosphate levels in the plasma and bone marrow of children with acute leukemia].
Topics: Acute Disease; Adolescent; Bone Marrow; Child; Child, Preschool; Humans; Infant; Leukemia; Pyridoxal | 1987 |